Exchange: NASDAQ·Updated 04:10 PM EST
ATHE logo

ATHE Alterity Therapeutics Ltd - ADR

$1.71
$0.165
(8.85%)
Today
Closed $1.70
$0.01
(0.59%)
After Hours
Mkt Cap$35.61M
Vol25,513.00

About ATHE

Alterity Therapeutics Ltd. engages in the business of research and development of therapeutic drugs designed to treat neurodegenerative diseases, focusing on Parkinsonian and other movement disorders. Its lead candidate, ATH434, is an oral small molecule drug designed to inhibit the aggregation of pathological proteins implicated in neurodegeneration. The company was founded by Geoffrey Paul Kempler on November 11, 1997 and is headquartered in Melbourne, Australia.
49

Neutral Sentiment

How do you feel about ATHE?

ButcherBillCutting
$ATHE Added more yesterday and today. No MM, no short, no nothing going To break my spirit here 😂 I remember when it was a ghost town 2 Years ago before the p2 data and I was Buying under $1.50 Best peak I saw was in the $7.00s Do your DD on Stamler & Company Insane mis valuation here I’m buying blood whenever I can For as long as I can until the reversal GL to all
7
Bob_Coyle
$ATHE so we finished at 183X normal volume. The bulk of the buys underwater. Who was desperate to build a 3m+ share position in one day... ASX rules require filing within 2 days for positions over 5%. Tick tok
6
Botmax
$ATHE The company just changed the terms of the CEOs employment and separation payment regarding M&A.
1
3
GA09
$ATHE On the positive side, CEO stated they continue to have "ongoing discussions" & "new prospective partners" are also speaking to ATHE & CEO and the Management Team is aware of the dilution risk to existing shareholders if they go the capital raise route. He said they are looking at multiple approaches and they will only agree on a partnership if that partner is willing to develop 434 along with them and support them (fully) through out the process and not simply finance the trial only to drop off later and for ATHE to do a capital raise (in between the trial) and dilute the existing shareholders. He also said they have sufficient capital for the "initial phase of the trial" which means they know that the trial will be costly and they will (eventually) need funding for the full trial which is why they are looking at a potential partnership structure. Wall Street is not confident they find a partner given the sell off in the stock price. CEO has to prove them wrong soon!!!!
5
Dingo2
$ATHE I guess it's early Black Friday sale time. Going to have to bust open the piggy bank 🙃
4
GA09
$ATHE I listened to the Fireside Chat (this morning) & CEO was asked about plans for financing the Phase 3 trial. He did say they are getting new prospective partners and continuing to have discussions BUT they are also looking at a capital raise (which he admitted was a concern to existing shareholders due to dilution) only if the partner does not provide the value they are looking for in advancing 434 to ultimately being approved by the FDA. He said they are not simply looking for a partner to finance the Phase 3 trial but a strategic partner that is going to bring value to 434. It appears (so far) the partners are not offering the strategic value ATHE is looking for in a partner. Honestly, CEO did not seem optimistic on securing a partner (given his tone) BUT he is also not in support for a capital raise causing dilution. He did say they are still having "ongoing discussions" with potential partners. The partner should be "thoughtful development partner" & not simply a finance.
4
GA09
$ATHE Released on October 29th. Positive comments on discussions with "a number of pharmaceutical companies" & in alignment to what the CEO said recently about Management's and shareholders' "angst" on being diluted, they state "and maximizes long-term shareholder value" which implies they prefer a strategic partnership instead of issuing shares and diluting patient shareholders and investors.
3
motherlandreturns
$ATHE woah what’s going on I hope a partnership is coming down the pipeline we have been waiting the whole year
2
AshleySchaeffer_BMW
$ATHE odd activity today, yanked it above 3 then back down, thesis remains, moon soon here...
2
MRenton
$ATHE The bullish interpretation is that protecting unvested compensation can reduce a CEO’s personal resistance to selling the company
2
SeriousVikingTrades
Thanks for keeping me green in this red market. Made $5.2K profits :) Make sure you drop a Follow to below. Actually a pretty good trader 🔥🚀 $ATHE $GNS top watch in to close for news and squeeze
1
SaylorsPonz
$ATHE good thing $PARA.X is not listed here , else some or those 68 million bags might be you !!! $MERC $GRAB the popcorn
1

Advertisement|Remove ads.